spacer
home > ebr > winter 2019 > consent and biospecimen collection in human research
PUBLICATIONS
European Biopharmaceutical Review

Consent and Biospecimen Collection in Human Research

Regulations governing the protection of human research subjects are based on the ethical principles identified in the Belmont Report: “respect for persons, beneficence, and justice” and in the Nuremberg Code and the Declaration of Helsinki (1-3). Guidelines established by the Council for the International Organization of Medical Sciences, the Nuffield Council on Bioethics, and Good Clinical Practice also contributed (4-6). The application of these principles in the use of human biospecimens in research is enforced by legal and ethical regulations, the most important of which relates to permission. This may come directly from the donor or be granted by others with authorisation to protect the interests of biospecimen donors.

Legal and ethical oversight is country/region-specific. In the UK, consent or authorisation is required for the collection of biospecimens for research from both living and deceased donors, with a similar situation existing in other European countries. However, in the UK, whether or not a research study also requires ethical approval by an independent ethics committee (IEC) can be determined via an online tool provided by the Health Research Authority (7). In the US, institutional review boards (IRBs) are responsible for the regulatory oversight of research involving human subjects, with the Office of Human Research Protection (OHRP) 45 CFR Part 46 regulations governing IRBs and their operation (8). In other countries, the ministries of health (MOH) or their equivalent may be responsible or may transfer the responsibility to authorised IECs.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Tony Brown is Senior Director of Scientific and Corporate Development at BioIVT. Kelly Sapsford is General Manager for the UK and Europe at BioIVT.
Print this page
Send to a friend
Privacy statement
News and Press Releases

Distributor Oppurtunities

Have an appetite for success – Want to expand your product portfolio – Fancy being part of something special??
More info >>

White Papers

Tightening Your Supply Chain Against Counterfeits

World Courier

As today’s global pharmaceutical supply chain grows increasingly longer and more complex, each link provides added opportunity for counterfeiters. While pending regulatory changes promise to tighten the supply chain with respect to production and distribution entities and new packaging technologies will make the identification of counterfeit products easier, the logistics of global distribution remains a weak link. How can the pharmaceutical shipper ensure the security of the supply chain over thousands of miles and extended periods of time when the product is no longer in his possession?
More info >>

 
Industry Events

Nordic Life Science Days 10/12 September 2019

10-12 September 2019, Malmo Sweden

Nordic Life Science Days is the largest Nordic partnering conference for the global Life Science industry. Bringing together the best talents in Life Science, offering amazing networking and partnering opportunities, providing inputs and content on the most recent trends. Nordic Life Science Days attracts leading decision makers from the Life Science sector, not only from biotech, pharma and medtech but also from finances, research, policy and regulatory authorities.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement